Novel psychoactive substances
High Resolution Mass Spectrometry Drug Screening in Forensic Toxicology: A Cost Benefit Analysis
Date Published
2022
Agencies
NIJ-Sponsored
Analytical Studies on the 2-naphthoyl substituted-l-n-pentylindoles Regioisomeric Synthetic Cannabinoids
Date Published
March 2018
Agencies
NIJ-Sponsored
Stability of Synthetic Cathinones in Urine
Journal
Date Published
March 2018
Agencies
NIJ-Sponsored
Identification and Quantification of Synthetic Cathinones in Blood and Urine Using Liquid Chromatography-Quadrupole/Time of Flight (LC-Q/TOF) Mass Spectrometry
Date Published
November 2016
Agencies
NIJ-Sponsored
A Data-Informed Response to Emerging Drugs
December 2023
Series
The emerging drug crisis in the U.S. touches both criminal justice and public health, and experts from both fields came together at NIJ’s 2023 National Research Conference to discuss strategies and tools to fight this problem. Dr. Frances Scott, NIJ scientist and program manager, continues the conference discussion with two fellow panelists: Ciena Bayard, the Method Development and Validation Program Manager for D.C. Office of the Chief Medical Examiner, and Haley Greene, the Deputy Epidemiologist for the Central Region for the Virginia Department of Health. Read the transcript.
Transcript
Audio file
New Systematic Naming for Synthetic Cannabinoid “MDA-19” and Its Related Analogues: BZO-HEXOXIZID, 5F-BZO-POXIZID, and BZO-POXIZID
Date Published
2021
Agencies
NIJ-Sponsored
New Synthetic Opioid Protonitazene Increasing in Prevalence as "Nitazenes" Gain Traction Across the United States and Canada
Date Published
2021
Agencies
NIJ-Sponsored